Fetal pancreatic enlargement associated with gestational diabetes mellitus occurs earlier than the conventional clinical diagnostic window and exhibits a developmental trajectory that is temporally dissociated from overall truncal growth, according to a prenatal ultrasound study published in Archives of Gynecology and Obstetrics. Conducted by researchers Dan Guo, Hong Yin, Jinfeng Xue, Jing Liu, Ying Zhu, and Dequan Liu, the clinical investigation tracked fetal anatomical dimensions across gestation to characterize how maternal gestational diabetes mellitus influences fetal pancreatic development. The findings demonstrate that structural alterations within the fetal pancreas emerge prior to the gestational stages at which diabetes is typically identified during routine pregnancy care.
The primary objective of the investigation was to evaluate the precise impact of gestational diabetes mellitus on fetal pancreatic development using prenatal ultrasound imaging, while delineating gestational age-specific growth patterns in affected fetuses. To map these developmental trajectories, the research team conducted an observational cohort study enrolling 540 total pregnancies evaluated across the second and third trimesters between 15 and 39 weeks of gestation. The research cohort comprised 408 normoglycemic control pregnancies alongside 132 pregnancies complicated by gestational diabetes mellitus, providing comparative data across multiple gestational stages.
During the serial ultrasound examinations, the investigators measured specific fetal anatomical metrics, including fetal pancreatic circumference, fetal pancreatic area, and fetal abdominal circumference across the 15 to 39 week gestational window. From these primary biometric dimensions, the researchers calculated the ratio of abdominal circumference to pancreatic circumference for each developing fetus. Using the biometric data derived from the 408 normoglycemic control pregnancies, the investigators constructed mathematical reference equations to model expected pancreatic circumference and pancreatic area relative to advancing gestational age. These baseline reference equations demonstrated high goodness of fit, achieving an R-squared value of 0.9778 for pancreatic circumference and an R-squared value of 0.9441 for pancreatic area.
To evaluate whether gestational diabetes mellitus independently correlated with fetal pancreatic alterations, the investigators conducted multiple linear regression modeling that adjusted for potential confounding factors. Following confounder adjustment, gestational diabetes mellitus independently predicted increases in both fetal pancreatic circumference and fetal pancreatic area, with both associations achieving statistical significance at probability values of less than 0.001. In addition, the researchers employed analysis of covariance across gestational age subgroups, which demonstrated statistically significant interaction effects between gestational diabetes mellitus status and gestational age for pancreatic circumference, pancreatic area, and abdominal circumference, with all interactions yielding probability values of less than 0.01.
Subgroup comparisons conducted across specific gestational age windows revealed distinct timing in the manifestation of pancreatic enlargement in fetuses of mothers with gestational diabetes mellitus. Significant enlargement of the fetal pancreas was clearly evident between 20 and 31 weeks of gestation, reaching its maximal degree of difference compared to normoglycemic controls during the window between 28 and 31 weeks of gestation. Conversely, ultrasound measurements taken during the earlier gestational window of 15 to 19 weeks and the later gestational window of 32 to 39 weeks revealed no statistically significant differences in pancreatic circumference or area between the two study groups.
Fetal abdominal circumference displayed a distinct biphasic growth pattern that differed markedly from the developmental trajectory observed in the pancreas. In the gestational diabetes group, abdominal circumference was significantly increased between 20 and 23 weeks of gestation but was significantly decreased between 32 and 39 weeks of gestation, with no statistically significant differences observed at any other gestational windows. Furthermore, the calculated ratio of abdominal circumference to pancreatic circumference was significantly lower in the gestational diabetes cohort than in normoglycemic controls from 20 weeks of gestation onward, with every comparison showing statistical significance at probability values below 0.05. The largest difference in this ratio between the two groups occurred between 24 and 27 weeks of gestation.
In their conclusion, the authors noted that fetal pancreatic enlargement in pregnancies complicated by gestational diabetes mellitus develops earlier than the standard clinical diagnostic window. The researchers emphasized that the distinct temporal dissociation observed between pancreatic growth and truncal abdominal growth indicates that maternal gestational diabetes mellitus induces a more sustained and less reversible morphological alteration in the developing fetal pancreas than in overall fetal somatic measurements.
Subject of Research: Fetal pancreatic development in gestational diabetes mellitus
Article Title: Prenatal ultrasound study on the effect of gestational diabetes mellitus on fetal pancreatic development
Article References: Guo, D., Yin, H., Xue, J., Liu, J., Zhu, Y., & Liu, D. (2026). Prenatal ultrasound study on the effect of gestational diabetes mellitus on fetal pancreatic development. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-026-08565-2
Image Credits: AI Generated
DOI: 10.1007/s00404-026-08565-2
Keywords: gestational diabetes mellitus, prenatal ultrasound, fetal pancreatic development, pancreatic circumference, pancreatic area, abdominal circumference, fetal growth, obstetrics, Prenatal, ultrasound, effect, gestational
